These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7966058

  • 1. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity.
    Chalmers A, Scheifele D, Patterson C, Williams D, Weber J, Shuckett R, Teufel A.
    J Rheumatol; 1994 Jul; 21(7):1203-6. PubMed ID: 7966058
    [Abstract] [Full Text] [Related]

  • 2. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
    van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2010 Jan; 62(1):75-81. PubMed ID: 20039396
    [Abstract] [Full Text] [Related]

  • 3. [Vaccination against influenza in patients with rheumatoid arthritis: clinical and antibody response].
    Francioni C, Rosi P, Fioravanti A, Megale F, Pipitone N, Marcolongo R.
    Recenti Prog Med; 1996 Apr; 87(4):145-9. PubMed ID: 8643873
    [Abstract] [Full Text] [Related]

  • 4. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O.
    Ann Rheum Dis; 2008 Jul; 67(7):937-41. PubMed ID: 17981914
    [Abstract] [Full Text] [Related]

  • 5. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
    Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R, Cardelli P, Rossi F, D'Amelio R.
    Vaccine; 2006 Apr 12; 24(16):3217-23. PubMed ID: 16466833
    [Abstract] [Full Text] [Related]

  • 6. Influenza immunization in children with chronic arthritis: a prospective study.
    Malleson PN, Tekano JL, Scheifele DW, Weber JM.
    J Rheumatol; 1993 Oct 12; 20(10):1769-73. PubMed ID: 7848389
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis.
    Elkayam O.
    Clin Dev Immunol; 2006 Oct 12; 13(2-4):349-51. PubMed ID: 17162376
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.
    Elkayam O, Amir S, Mendelson E, Schwaber M, Grotto I, Wollman J, Arad U, Brill A, Paran D, Levartovsky D, Wigler I, Caspi D, Mandelboim M.
    Arthritis Care Res (Hoboken); 2011 Jul 12; 63(7):1062-7. PubMed ID: 21425247
    [Abstract] [Full Text] [Related]

  • 9. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 12; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 10. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
    Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM.
    Ann Rheum Dis; 2011 Dec 12; 70(12):2144-7. PubMed ID: 21859696
    [Abstract] [Full Text] [Related]

  • 11. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 12; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial.
    Chiu SS, Chan KH, Tu W, Lau YL, Peiris JS.
    Vaccine; 2009 Jul 30; 27(35):4834-9. PubMed ID: 19523908
    [Abstract] [Full Text] [Related]

  • 13. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
    Stojanovich L.
    Clin Dev Immunol; 2006 Jul 30; 13(2-4):373-5. PubMed ID: 17162380
    [Abstract] [Full Text] [Related]

  • 14. Effective immunization against influenza in pediatric renal transplant recipients.
    Edvardsson VO, Flynn JT, Deforest A, Kaiser BA, Schulman SL, Bradley A, Palmer J, Polinsky MS, Baluarte HJ.
    Clin Transplant; 1996 Dec 30; 10(6 Pt 1):556-60. PubMed ID: 8996778
    [Abstract] [Full Text] [Related]

  • 15. Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study.
    Wongsurakiat P, Maranetra KN, Gulprasutdilog P, Aksornint M, Srilum W, Ruengjam C, Sated W.
    Respirology; 2004 Nov 30; 9(4):550-6. PubMed ID: 15612969
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR, Rizzone C, DeMello S, Ogra PL.
    Dev Biol Stand; 1976 Nov 30; 33():162-70. PubMed ID: 782964
    [Abstract] [Full Text] [Related]

  • 17. Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.
    Kivitz AJ, Schechtman J, Texter M, Fichtner A, de Longueville M, Chartash EK.
    J Rheumatol; 2014 Apr 30; 41(4):648-57. PubMed ID: 24584918
    [Abstract] [Full Text] [Related]

  • 18. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
    Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL, American Lung Association Asthma Clinical Research Centers.
    J Allergy Clin Immunol; 2004 Apr 30; 113(4):717-24. PubMed ID: 15100679
    [Abstract] [Full Text] [Related]

  • 19. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.
    Vesikari T, Pellegrini M, Karvonen A, Groth N, Borkowski A, O'Hagan DT, Podda A.
    Pediatr Infect Dis J; 2009 Jul 30; 28(7):563-71. PubMed ID: 19561422
    [Abstract] [Full Text] [Related]

  • 20. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2009 Aug 30; 60(8):2438-47. PubMed ID: 19644961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.